Author
Listed:
- Albert S. Agustinus
(Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine)
- Duaa Al-Rawi
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Bhargavi Dameracharla
(University of California, San Diego)
- Ramya Raviram
(New York Genome Center)
- Bailey S. C. L. Jones
(Yale University School of Medicine)
- Stephanie Stransky
(Albert Einstein College of Medicine)
- Lorenzo Scipioni
(University of California, Irvine)
- Jens Luebeck
(University of California, San Diego)
- Melody Bona
(Memorial Sloan Kettering Cancer Center)
- Danguole Norkunaite
(Memorial Sloan Kettering Cancer Center)
- Robert M. Myers
(New York Genome Center
Tri-institutional MD-PhD Program)
- Mercedes Duran
(Memorial Sloan Kettering Cancer Center)
- Seongmin Choi
(Memorial Sloan Kettering Cancer Center)
- Britta Weigelt
(Memorial Sloan Kettering Cancer Center)
- Shira Yomtoubian
(Weill Cornell Medicine)
- Andrew McPherson
(Memorial Sloan Kettering Cancer Center)
- Eléonore Toufektchan
(Memorial Sloan Kettering Cancer Center)
- Kristina Keuper
(University of Kaiserslautern)
- Paul S. Mischel
(Stanford University)
- Vivek Mittal
(Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine)
- Sohrab P. Shah
(Memorial Sloan Kettering Cancer Center)
- John Maciejowski
(Memorial Sloan Kettering Cancer Center)
- Zuzana Storchova
(University of Kaiserslautern)
- Enrico Gratton
(University of California, Irvine)
- Peter Ly
(University of Texas Southwestern Medical Center)
- Dan Landau
(New York Genome Center
Weill Cornell Medicine)
- Mathieu F. Bakhoum
(Yale University School of Medicine
Yale University School of Medicine
Yale University)
- Richard P. Koche
(Memorial Sloan Kettering Cancer Center)
- Simone Sidoli
(Albert Einstein College of Medicine)
- Vineet Bafna
(University of California, San Diego)
- Yael David
(Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Tri-institutional PhD Program in Chemical Biology)
- Samuel F. Bakhoum
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
Abstract
Chromosomal instability (CIN) and epigenetic alterations are characteristics of advanced and metastatic cancers1–4, but whether they are mechanistically linked is unknown. Here we show that missegregation of mitotic chromosomes, their sequestration in micronuclei5,6 and subsequent rupture of the micronuclear envelope7 profoundly disrupt normal histone post-translational modifications (PTMs), a phenomenon conserved across humans and mice, as well as in cancer and non-transformed cells. Some of the changes in histone PTMs occur because of the rupture of the micronuclear envelope, whereas others are inherited from mitotic abnormalities before the micronucleus is formed. Using orthogonal approaches, we demonstrate that micronuclei exhibit extensive differences in chromatin accessibility, with a strong positional bias between promoters and distal or intergenic regions, in line with observed redistributions of histone PTMs. Inducing CIN causes widespread epigenetic dysregulation, and chromosomes that transit in micronuclei experience heritable abnormalities in their accessibility long after they have been reincorporated into the primary nucleus. Thus, as well as altering genomic copy number, CIN promotes epigenetic reprogramming and heterogeneity in cancer.
Suggested Citation
Albert S. Agustinus & Duaa Al-Rawi & Bhargavi Dameracharla & Ramya Raviram & Bailey S. C. L. Jones & Stephanie Stransky & Lorenzo Scipioni & Jens Luebeck & Melody Bona & Danguole Norkunaite & Robert M, 2023.
"Epigenetic dysregulation from chromosomal transit in micronuclei,"
Nature, Nature, vol. 619(7968), pages 176-183, July.
Handle:
RePEc:nat:nature:v:619:y:2023:i:7968:d:10.1038_s41586-023-06084-7
DOI: 10.1038/s41586-023-06084-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:619:y:2023:i:7968:d:10.1038_s41586-023-06084-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.